Meier JA, Zhang F, Sanjana NE. GUIDES: sgRNA design for loss-of-function screens. Nat Methods. 2017;14(9):831-832. doi:10.1038/nmeth.4423
Fonseka CY, Rao DA, Raychaudhuri S. Leveraging blood and tissue CD4+ T cell heterogeneity at the single cell level to identify mechanisms of disease in rheumatoid arthritis. Curr Opin Immunol. 2017;49:27-36. doi:10.1016/j.coi.2017.08.005
Tripathy D, Bardia A, Sellers WR. Mechanism of Action and Clinical Impact of Ribociclib-Response. Clin Cancer Res. 2017;23(18):5658. doi:10.1158/1078-0432.CCR-17-1819
Sabeti PC, Reich DE, Higgins JM, et al. Detecting recent positive selection in the human genome from haplotype structure. Nature. 2002;419(6909):832-7. doi:10.1038/nature01140
Steinebach C, Lindner S, Udeshi ND, et al. Homo-PROTACs for the Chemical Knockdown of Cereblon. ACS Chem Biol. 2018;13(9):2771-2782. doi:10.1021/acschembio.8b00693
Demontis D, Walters RK, Martin J, et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat Genet. 2019;51(1):63-75. doi:10.1038/s41588-018-0269-7
Gusev A, Mancuso N, Won H, et al. Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights. Nat Genet. 2018;50(4):538-548. doi:10.1038/s41588-018-0092-1
Olsen L, Sparsø T, Weinsheimer SM, et al. Prevalence of rearrangements in the 22q11.2 region and population-based risk of neuropsychiatric and developmental disorders in a Danish population: a case-cohort study. Lancet Psychiatry. 2018;5(7):573-580. doi:10.1016/S2215-0366(18)30168-8
van der Merwe C, Mwesiga EK, McGregor NW, et al. Advancing neuropsychiatric genetics training and collaboration in Africa. Lancet Glob Health. 2018;6(3):e246-e247. doi:10.1016/S2214-109X(18)30042-1
Gershon ES, Pearlson G, Keshavan MS, et al. Genetic analysis of deep phenotyping projects in common disorders. Schizophr Res. 2018;195:51-57. doi:10.1016/j.schres.2017.09.031